Kuala Lumpur (AFP) | 10/07/2025 - 10:30:45 | US has 'no intention of abandoning' Asia region: Rubio
Dubai (AFP) | 10/07/2025 - 10:23:22 | Four more rescued, 10 total, from ship sunk by Huthis in Red Sea: EU force
Port Sudan (AFP) | 10/07/2025 - 10:19:17 | Eight killed in Sudan paramilitary attack on shelter: medical source
Sanaa (AFP) | 10/07/2025 - 09:51:17 | Yemen's Huthis claim missile attack targeting Israel
London (AFP) | 10/07/2025 - 09:36:32 | London's FTSE 100 hits new record on US tariff optimism
Beijing (AFP) | 10/07/2025 - 09:32:27 | China says after US copper levy that 'arbitrary' tariffs serve no one
Beijing (AFP) | 10/07/2025 - 09:16:33 | China says 'verifying' case of citizens held for alleged spying in Ukraine
Islamabad (AFP) | 10/07/2025 - 09:10:52 | Pakistan police arrest 149, including 48 Chinese, in scam centre raid
Gaza City (AFP) | 10/07/2025 - 09:06:41 | Gaza civil defence says 23 killed in Israeli strikes
Kyiv (AFP) | 10/07/2025 - 08:47:44 | Zelensky urges faster sanctions after deadly Kyiv strike
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
AFP takes part to the 7th photography festival in Leipzig f/stop, Germany, from June 25th until July 3rd, 2016.
The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO’s strategic direction and ensure the organization’s continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape. This press release features multimedia. View the full rel...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive ...
